Retractable Technologies
About: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
Employees: 151
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
0.39% more ownership
Funds ownership: 7.47% [Q2] → 7.86% (+0.39%) [Q3]
11% less funds holding
Funds holding: 35 [Q2] → 31 (-4) [Q3]
25% less capital invested
Capital invested by funds: $2.42M [Q2] → $1.81M (-$605K) [Q3]
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Research analyst outlook
We haven’t received any recent analyst ratings for RVP.